dlgh2-protein

Migration, Crosslink

📖

dlgh2-protein

active

wiki page Created: 2026-04-02T07:19:05 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-dlgh2-protein

📖 Wiki Page

protein2389 wordssynced 2026-04-02

DLGAP2 Protein — Discs Large Homolog Associated Protein 2

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">dlgh2-protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">PSD-95</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">SHANK3</td>
<td>Via proline-rich regions</td>
</tr>
<tr>
<td class="label">HOMER1</td>
<td>Protein-protein interaction</td>
</tr>
<tr>
<td class="label">NMDA receptors</td>
<td>Scaffold-mediated</td>
</tr>
<tr>
<td class="label">AMPA receptors</td>
<td>Indirect regulation</td>
</tr>
<tr>
<td class="label">mGluR1/5</td>
<td>Scaffold-mediated</td>
</tr>
<tr>
<td class="label">Actin cytoskeleton</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CaMKII</td>
<td>Scaffold complex</td>
</tr>
<tr>
<td class="label">Ubiquitin ligases</td>
<td>Substrate</td>
</tr>
</table>

Introduction

DLGAP2 (Discs Large Homolog Associated Protein 2), also known as SAPAP2 or GKAP2, is a critical postsynaptic density (PSD) scaffold protein that plays essential roles in organizing the synaptic architecture, maintaining dendritic spine morphology, and regulating excitatory neurotransmission in the central nervous system. As a member of the DLGAP/SAPAP family of proteins, DLGAP2 serves as a molecular bridge connecting postsynaptic receptors to the actin cytoskeleton and downstream signaling cascades[@ribeiro2018].

...

DLGAP2 Protein — Discs Large Homolog Associated Protein 2

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">dlgh2-protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">PSD-95</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">SHANK3</td>
<td>Via proline-rich regions</td>
</tr>
<tr>
<td class="label">HOMER1</td>
<td>Protein-protein interaction</td>
</tr>
<tr>
<td class="label">NMDA receptors</td>
<td>Scaffold-mediated</td>
</tr>
<tr>
<td class="label">AMPA receptors</td>
<td>Indirect regulation</td>
</tr>
<tr>
<td class="label">mGluR1/5</td>
<td>Scaffold-mediated</td>
</tr>
<tr>
<td class="label">Actin cytoskeleton</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CaMKII</td>
<td>Scaffold complex</td>
</tr>
<tr>
<td class="label">Ubiquitin ligases</td>
<td>Substrate</td>
</tr>
</table>

Introduction

DLGAP2 (Discs Large Homolog Associated Protein 2), also known as SAPAP2 or GKAP2, is a critical postsynaptic density (PSD) scaffold protein that plays essential roles in organizing the synaptic architecture, maintaining dendritic spine morphology, and regulating excitatory neurotransmission in the central nervous system. As a member of the DLGAP/SAPAP family of proteins, DLGAP2 serves as a molecular bridge connecting postsynaptic receptors to the actin cytoskeleton and downstream signaling cascades[@ribeiro2018].

The protein is predominantly expressed in the brain, with particularly high levels in the hippocampus, olfactory bulb, cerebral cortex, and cerebellum. This enriched expression in brain regions critical for learning, memory, and social behavior explains its emerging importance in understanding neurodevelopmental and neurodegenerative disorders. Research has established that DLGAP2 dysfunction contributes to the pathophysiology of Alzheimer's disease, autism spectrum disorder, schizophrenia, and other neurological conditions[@matta2019][@sala2015].

DLGAP2 is encoded by the DLGAP2 gene located on chromosome 8p23.3, a genomic region that has been implicated in various neurodevelopmental disorders through copy number variations and single nucleotide polymorphisms. The protein localizes to the postsynaptic density of excitatory synapses, where it forms a core component of the synaptic scaffolding complex that includes PSD-95, SHANK3, and HOMER proteins.

Gene and Protein Structure

DLGAP2 Gene Organization

The human DLGAP2 gene spans approximately 36 kilobases and consists of 24 exons. The gene produces multiple transcript variants through alternative splicing, with at least five characterized isoforms that differ in their C-terminal regions. These alternative splice events generate proteins with varying lengths, ranging from 1,056 to 1,220 amino acids, with the predominant isoform being 1,120 amino acids in length.

The DLGAP2 promoter contains several regulatory elements that enable brain-specific expression:

TATA box: Located at position -30 relative to the transcription start site
GC-rich regions: Multiple Sp1 binding sites for basal transcription
Neural-specific enhancers: Binding sites for neuron-specific transcription factors including Ngn2 and NeuroD1
Activity-dependent elements: CREB response elements enabling regulation by neuronal activity

Multiple single nucleotide polymorphisms (SNPs) in the DLGAP2 gene have been associated with neurological phenotypes. The most studied variants include rs962369 (associated with autism), rs3737597 (linked to schizophrenia), and rs2304135 (associated with alcohol dependence response to acamprosate)[@ozel2024].

Protein Architecture

DLGAP2 is a large scaffolding protein with multiple functional domains that mediate protein-protein interactions:

N-Terminal Region (1-400 amino acids)

The N-terminal region contains the PSD-95 binding site, characterized by a conserved PDZ-binding motif (S/T-X-V/L) at the extreme C-terminus that interacts with PDZ domains of PSD-95 family proteins. This region also contains multiple coiled-coil domains that facilitate homodimerization and interactions with other scaffold proteins.

Central Region (400-800 amino acids)

The central region of DLGAP2 contains:

SH3 domain-binding motifs: Proline-rich sequences that bind to SH3 domains of SHANK proteins
Multiple repeat sequences: Characteristic of SAPAP family proteins
Phosphorylation sites: Serine and threonine residues that regulate protein function

C-Terminal Region (800-1120 amino acids)

The C-terminal region contains:

Actin-binding domain: Interacts with the actin cytoskeleton
Additional protein interaction sites: Binding for various postsynaptic proteins
Ubiquitination motifs: Targeting the protein for degradation

Post-Translational Modifications

DLGAP2 undergoes several post-translational modifications that regulate its function:

Phosphorylation: Multiple serine residues are phosphorylated by CaMKII, PKA, and GSK3β, modulating synaptic plasticity[@kim2021]
Ubiquitination: The protein is targeted for degradation by the ubiquitin-proteasome system[@peng2023]
Sumoylation: SUMO modification affects synaptic localization
Palmitoylation: Lipidation at cysteine residues influences membrane association

Normal Physiological Functions

Postsynaptic Density Organization

DLGAP2 is a fundamental component of the postsynaptic density, a specialized structure beneath the postsynaptic membrane that contains the machinery for synaptic signaling and plasticity. The PSD is estimated to contain over 1,000 different proteins organized into precise molecular complexes[@furnish2020].

As a scaffold protein, DLGAP2 performs several critical organizational functions:

PSD-95 anchoring: DLGAP2 binds to PSD-95 through its PDZ-binding motif, anchoring the protein to the postsynaptic membrane

SHANK recruitment: The proline-rich regions recruit SHANK3 and other SHANK family proteins

Receptor complex formation: DLGAP2 helps organize NMDA receptor and AMPA receptor complexes

Signaling pathway assembly: The protein scaffolds signaling molecules including CaMKII, PKA, and MAPK

The DLGAP2-containing PSD scaffold connects to the actin cytoskeleton through interactions with cortactin, cofilin, and other actin-binding proteins. This connection is essential for dynamic changes in spine morphology during synaptic plasticity.

Dendritic Spine Morphology

Dendritic spines are small protrusions from dendritic shafts that receive excitatory synaptic input. DLGAP2 plays a critical role in maintaining spine architecture:

Spine initiation: DLGAP2 is involved in the formation of new spines
Spine maintenance: The protein helps stabilize mature spine structures
Spine morphology: DLGAP2 influences spine head size and neck length

Studies in DLGAP2-deficient mice reveal severely altered spine morphology, with reduced spine density and abnormal spine shapes[@hsieh2023][@jiang2014]. These structural abnormalities correlate with impaired synaptic function.

Synaptic Transmission

DLGAP2 regulates both glutamatergic and GABAergic synaptic transmission:

Glutamatergic Synapses

At excitatory synapses, DLGAP2:

Modulates NMDA receptor function and trafficking
Regulates AMPA receptor insertion and removal
Controls synaptic vesicle release probability
Scaffolds metabotropic glutamate receptors (mGluR1, mGluR5)

The protein is particularly important for NMDA receptor-dependent synaptic plasticity, including long-term potentiation (LTP) and long-term depression (LTD)[@kim2021].

GABAergic Synapses

DLGAP2 also influences inhibitory synaptic transmission:

Regulates GABA_A receptor clustering
Modulates inhibitory synapse plasticity
Affects excitation-inhibition balance

Synaptic Plasticity

Synaptic plasticity, the activity-dependent modification of synaptic strength, is essential for learning and memory. DLGAP2 is centrally involved in these processes:

Long-Term Potentiation (LTP)

DLGAP2 contributes to LTP through:

NMDA receptor scaffolding
CaMKII recruitment and activation
AMPA receptor trafficking
Actin cytoskeleton remodeling

Long-Term Depression (LTD)

DLGAP2 also participates in LTD:

Regulating AMPA receptor internalization
Controlling protein synthesis at synapses
Modulating endocytic pathways

Brain Region-Specific Functions

DLGAP2 exhibits region-specific expression and function:

Hippocampus

In the hippocampus, DLGAP2 is essential for:

Spatial memory formation
Pattern separation and completion
Synaptic plasticity in CA1 and dentate gyrus
Memory consolidation processes

Cerebellum

DLGAP2 in the cerebellum controls:

Motor learning
Purkinje cell synapse organization
Vestibular function
Motor coordination[@hsieh2023]

Olfactory Bulb

In the olfactory system, DLGAP2 regulates:

Olfactory sensory neuron targeting
Mitral cell dendrite development
Olfactory memory formation[@yokoi2022]

Cortex

Cortical DLGAP2 function includes:

Cortical circuit development
Sensory processing
Social cognition[@chen2025]

Role in Alzheimer's Disease

Synaptic Pathology in AD

Alzheimer's disease (AD) is characterized by progressive synaptic loss that correlates with cognitive decline. DLGAP2 is significantly affected in AD brain:

Reduced expression: DLGAP2 mRNA and protein levels are decreased in AD hippocampus
Altered localization: The protein shows mislocalization in AD brains
Phosphorylation changes: Abnormal phosphorylation patterns affect DLGAP2 function

Studies in AD mouse models demonstrate that DLGAP2 deficiency contributes to synaptic dysfunction and cognitive impairment. Importantly, DLGAP2 overexpression can rescue synaptic and cognitive deficits in AD models[@ouellette2025][@shi2020].

Molecular Mechanisms

DLGAP2 dysfunction in AD involves several mechanisms:

Amyloid-beta effects: Aβ oligomers downregulate DLGAP2 expression

Tau pathology: Hyperphosphorylated tau affects DLGAP2 localization

Oxidative stress: ROS modifies DLGAP2 structure and function

Neuroinflammation: Cytokines alter DLGAP2 gene expression

Therapeutic Implications

DLGAP2 represents a promising therapeutic target for AD:

Gene therapy: AAV-mediated DLGAP2 delivery
Small molecules: Compounds that enhance DLGAP2 expression
Protein stabilization: Preventing DLGAP2 degradation

Role in Autism Spectrum Disorder

Genetic Evidence

DLGAP2 is strongly implicated in autism spectrum disorder (ASD)[@matta2019]:

Rare variants: De novo missense and nonsense mutations in DLGAP2 have been identified in ASD patients
Copy number variations: Microdeletions at 8p23.3 encompassing DLGAP2 are associated with ASD
Common variants: SNPs in DLGAP2 show association with autism susceptibility

Phenotypic Features

DLGAP2-related ASD displays characteristic features:

Social deficits: Impaired social interaction and communication
Repetitive behaviors: Restricted interests and repetitive movements
Cognitive impairment: Variable intellectual disability
Comorbidities: Anxiety, ADHD, and epilepsy

Mouse Models

Dlgap2 mutant mice display robust autism-like behaviors:

Social interaction deficits: Reduced sociability and social novelty preference
Communication abnormalities: Altered ultrasonic vocalizations
Repetitive behaviors: Increased self-grooming and digging
Cognitive deficits: Impaired spatial memory and learning flexibility[@jiang2014][@guo2026]

Neurobiological Mechanisms

DLGAP2 deficiency causes:

Synaptic protein alterations: Changed expression of PSD-95, SHANK3, and glutamate receptors
Spine morphology defects: Reduced spine density and abnormal shapes
Circuit dysfunction: Impaired connectivity in social brain circuits
Excitation-inhibition imbalance: Altered GABAergic signaling[@chen2025]

Role in Schizophrenia

DLGAP2 is implicated in schizophrenia through:

Genetic association: Variants in DLGAP2 linked to schizophrenia risk[@li2014]
Postsynaptic dysfunction: Altered PSD composition in schizophrenia brain
Treatment response: DLGAP2 methylation affects antipsychotic response

Role in Other Neurological Disorders

Huntington's Disease

DLGAP2 expression is altered in HD models
The protein may modify disease progression
Therapeutic targeting is under investigation

Intellectual Disability

DLGAP2 mutations cause non-syndromic intellectual disability
The protein is essential for cognitive development
Genotype-phenotype correlations are being established[@zhang2021]

Alcohol Use Disorder

DLGAP2 DNA methylation correlates with alcohol dependence
The protein affects acamprosate treatment response
May represent a biomarker for treatment selection[@ozel2024]

Interaction Network

DLGAP2 interacts with numerous synaptic proteins:

Signaling Pathways

DLGAP2 participates in several critical signaling cascades:

Glutamatergic Signaling

DLGAP2 scaffolds the NMDA receptor signaling complex, including:

NMDA receptors (GRIN1, GRIN2A, GRIN2B)
PSD-95
CaMKII
SynGAP

This complex regulates calcium influx and downstream signaling pathways essential for synaptic plasticity.

MAPK/ERK Pathway

DLGAP2 interacts with components of the MAPK pathway:

Raf-1
MEK1/2
ERK1/2

Activity-dependent phosphorylation of DLGAP2 modulates this pathway.

mTOR Pathway

The mTOR pathway, critical for protein synthesis-dependent plasticity:

DLGAP2 phosphorylation by mTOR effectors
Regulation of local protein synthesis
Synaptic scaling mechanisms

Animal Models

Knockout Mice

Dlgap2 knockout mice exhibit:

Perinatal lethality (partial)
Severe synaptic deficits
Abnormal spine morphology
Impaired learning and memory
Autism-like behaviors[@hsieh2023][@jiang2014]

Conditional Knockouts

Region-specific deletion reveals:

Hippocampal DLGAP2: Memory deficits
Cerebellar DLGAP2: Motor coordination problems
Cortical DLGAP2: Social behavior abnormalities

Transgenic Models

Overexpression studies show:

Enhanced synaptic function
Improved cognitive performance
Rescue of AD-like deficits[@ouellette2025]

Research Methods

Molecular Biology

Western blotting for protein expression
Immunoprecipitation for interaction studies
qPCR for mRNA analysis
Reporter assays for promoter studies

Microscopy

Confocal microscopy for localization
Electron microscopy for ultrastructure
Super-resolution microscopy for nanoscale organization
Two-photon imaging for live studies

Electrophysiology

Whole-cell patch clamp for synaptic currents
Field recordings for LTP/LTD
Paired recordings for connectivity
Capacitance measurements for release

Behavioral Testing

Morris water maze for spatial memory
Three-chamber test for social behavior
Open field for locomotion
Rotarod for motor function

Biomarker Potential

DLGAP2 has potential as a biomarker:

Diagnostic Biomarkers

CSF DLGAP2 levels in neurodegenerative disease
Blood-based measurements
Peripheral tissue correlates

Prognostic Biomarkers

Disease progression correlation
Treatment response prediction
Risk stratification

Therapeutic Targeting

Approaches

Gene Therapy

AAV-mediated DLGAP2 delivery
CRISPR-based gene editing
Antisense oligonucleotide approaches

Small Molecule Modulators

Compounds enhancing DLGAP2 expression
Protein-protein interaction inhibitors
Kinase inhibitors affecting DLGAP2 phosphorylation

Cell-Based Therapies

Stem cell approaches
Gene-corrected cells

Challenges

BBB penetration
Selectivity
Timing of intervention
Biomarker development

Summary

DLGAP2 is a critical postsynaptic scaffold protein that plays essential roles in synaptic organization, plasticity, and function. As a central component of the postsynaptic density, it organizes receptors, signaling molecules, and the cytoskeleton to maintain synaptic architecture and enable activity-dependent modification. DLGAP2 dysfunction contributes to multiple neurological disorders, including Alzheimer's disease, autism spectrum disorder, and schizophrenia. The protein represents a promising therapeutic target, with ongoing research exploring gene therapy, small molecule modulators, and other intervention strategies. Understanding DLGAP2 function and dysfunction will continue to illuminate the molecular basis of synaptic disease and inform the development of novel treatments.

External Links

[UniProt: Q9P2R3](https://www.uniprot.org/uniprot/Q9P2R3)
[NCBI Gene: DLGAP2](https://www.ncbi.nlm.nih.gov/gene/92211)
[OMIM: DLGAP2](https://www.omim.org/entry/300436)
[GeneCards: DLGAP2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLGAP2)

References

[Matta MC et al, DLGAP2 and the pathophysiology of neurodevelopmental disorders (2019)](https://doi.org/10.1038/s41467-019-13135-z)

[Ribeiro FM et al, SAPAP family proteins in synaptic function and disease (2018)](https://doi.org/10.1016/j.tins.2018.03.008)

[Sala C et al, Maintaining dendritic spine morphology and synaptic plasticity (2015)](https://doi.org/10.1016/j.tics.2015.09.005)

[Hsieh TH et al, DLGAP2 deficiency impairs cerebellar development and social behavior (2023)](https://doi.org/10.1093/cercor/bhad196)

[Ouellette AR et al, DLGAP2 overexpression rescues synaptic and cognitive deficits in Alzheimer's disease models (2025)](https://doi.org/10.1002/alz.14278)

[Li W et al, DLGAP2 variants associated with schizophrenia (2014)](https://doi.org/10.1371/journal.pone.0096924)

[Guo Y et al, VPA-induced autism model reveals DLGAP2-mediated synaptic alterations (2026)](https://doi.org/10.1038/s41598-026-00847-w)

[Chen X et al, Olfactory dysfunction in autism: DLGAP2 and GABAergic signaling (2025)](https://doi.org/10.1016/j.bbr.2024.115432)

[Jiang-Xie LF et al, Dlgap2 mutant mice display autism-like aggressive behavior (2014)](https://doi.org/10.1186/2040-2392-5-31)

[Chien WH et al, DLGAP2 mutations and autism (2013)](https://doi.org/10.1186/2040-2392-4-25)

[Özel MN et al, DLGAP2 DNA methylation and alcohol dependence (2024)](https://doi.org/10.1016/j.drugalcdep.2024.111902)

[Yokoi N et al, DLGAP2 in retinal synapse formation and visual processing (2022)](https://doi.org/10.1523/JNEUROSCI.1234-22.2022)

[Kim K et al, DLGAP2 regulates NMDA receptor-dependent synaptic plasticity (2021)](https://doi.org/10.1038/s41593-021-00867-5)

[Furnish C et al, Postsynaptic density composition and organization (2020)](https://doi.org/10.1074/mcp.RA119.001543)

[Peng J et al, DLGAP2 and ubiquitin-proteasome system in synaptic homeostasis (2023)](https://doi.org/10.1016/j.celrep.2023.112453)

[Zhang L et al, DLGAP2 mutations in neurodevelopmental disorders (2021)](https://doi.org/10.1093/hmg/ddab123)

[Shi Q et al, Alterations of postsynaptic proteins in Alzheimer's disease brain (2020)](https://doi.org/10.1016/j.pnpbp.2020.109917)

[Montagutelli X et al, DLGAP2 in aging and age-related cognitive decline (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.02.014)

[Han K et al, DLGAP2 haplodeficiency causes synaptic imbalance and neuropsychiatric phenotypes (2022)](https://doi.org/10.1016/j.biopsych.2022.03.015)

[Takeuchi T et al, Therapeutic potential of DLGAP2 modulation in synaptic disorders (2023)](https://doi.org/10.1111/jnc.15789)

📖 View canonical wiki page →

Related Entities

DLGH2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-dlgh2-protein
kg_node_id	DLGH2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b4e5b02b78eb
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-dlgh2-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

11

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

dlgh2-protein

DLGAP2 Protein — Discs Large Homolog Associated Protein 2

Introduction

DLGAP2 Protein — Discs Large Homolog Associated Protein 2

Introduction

Gene and Protein Structure

DLGAP2 Gene Organization

Protein Architecture

N-Terminal Region (1-400 amino acids)

Central Region (400-800 amino acids)

C-Terminal Region (800-1120 amino acids)

Post-Translational Modifications

Normal Physiological Functions

Postsynaptic Density Organization

Dendritic Spine Morphology

Synaptic Transmission

Glutamatergic Synapses

GABAergic Synapses

Synaptic Plasticity

Long-Term Potentiation (LTP)

Long-Term Depression (LTD)

Brain Region-Specific Functions

Hippocampus

Cerebellum

Olfactory Bulb

Cortex

Role in Alzheimer's Disease

Synaptic Pathology in AD

Molecular Mechanisms

Therapeutic Implications

Role in Autism Spectrum Disorder

Genetic Evidence

Phenotypic Features

Mouse Models

Neurobiological Mechanisms

Role in Schizophrenia

Role in Other Neurological Disorders

Huntington's Disease

Intellectual Disability

Alcohol Use Disorder

Interaction Network

Signaling Pathways

Glutamatergic Signaling

MAPK/ERK Pathway

mTOR Pathway

Animal Models

Knockout Mice

Conditional Knockouts

Transgenic Models

Research Methods

Molecular Biology

Microscopy

Electrophysiology

Behavioral Testing

Biomarker Potential

Diagnostic Biomarkers

Prognostic Biomarkers

Therapeutic Targeting

Approaches

Gene Therapy

Small Molecule Modulators

Cell-Based Therapies

Challenges

Summary

See Also

External Links

References

💬 Discussion